Whilst BMP7 recombinant protein has shown beneficial effects in the prevention of fibrosis in heart failure in preclinical mouse models [15,16], the cost of ongoing administration of recombinant BMP7 protein to HF patients is a major issue that hinders its progression for therapeutic application [27]. Here, BMP7 is linked to heart failure.